ARANTZA
MENDIZABAL ABAD
Investigador/a en el periodo 2010-2020
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadoras/es de Hospital de Cruces (2)
2022
-
Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75-year-olds newly diagnosed with multiple myeloma
European Journal of Haematology
2021
-
Faggot cells in therapy-related acute myeloid leukemia with inv(16)
Clinical Case Reports, Vol. 9, Núm. 1, pp. 572-573